<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR67">
 <label>67.</label>
 <mixed-citation publication-type="other">Zumla A, Wang F, Ippolito G, Petrosillo N, Agrati C, Azhar E, et al. Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy — Achieving global consensus and visibility for cellular host-directed therapies. Int J Infect Dis. 2020;96:431–439.</mixed-citation>
</ref>
